AgingResearch.NewsJoin free

Genor Biopharma

CompanyChinaFounded 2017

Genor Biopharma develops one asset, in phase 3 (GB242 in rheumatoid arthritis). Mostly small molecule acting on inflammation; based in China, founded in 2017.

1
Asset
Furthest stage
Phase 3
5
Trials
0
Signals

Pipeline

1

  • GB242

    Involved in one-carbon metabolism and nucleotide synthesis, co-administered in antifolate therapy

    Phase 3, Small molecule, Inflammation, rheumatoid arthritis

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Evidence behind the mechanisms2
  • Trials5
  • Similar companies6

Intelligence